Statement from National HBPA CEO on FTC Order to Not Approve HISA Drug and Medication Rules
Statement from National HBPA CEO Eric Hamelback on the Federal Trade Commission's order to not approve the Horseracing Integrity & Safety Authority's Anti-Doping and Medication Control rules that were to go into effect Jan. 1: "The recent FTC decision is another positive step forward for horsemen in our battle against the unconstitutional takeover of our industry. [...]
